Mirum Pharmaceuticals (MIRM) Cash from Operations (2019 - 2026)

Mirum Pharmaceuticals' Cash from Operations history runs 8 years deep, the most recent figure standing at 228763000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations fell 11565.63% year-over-year to 228763000.0 in Q1 2026; TTM through Mar 2026 was 170975000.0, a 2396.71% decrease from a year earlier, with the FY2025 full-year figure at 55827000.0, up 440.7% from the prior year.
• Cash from Operations fell to 228763000.0 in Q1 2026 per MIRM's latest filing, from 6067000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 39681000.0 in Q3 2025 and bottomed at 228763000.0 in Q1 2026.
• The 5-year median for Cash from Operations is 16618000.0 (2023), against an average of 20805352.94.
• Across the five-year window, Cash from Operations jumped 896.01% in 2025 and slumped 11565.63% in 2026, its largest moves.
• Year by year, Cash from Operations stood at 34270000.0 in 2022, then surged by 51.51% to 16618000.0 in 2023, then surged by 69.5% to 5068000.0 in 2024, then surged by 219.71% to 6067000.0 in 2025, then plunged by 3870.61% to 228763000.0 in 2026.
• Per Business Quant, the three latest MIRM Cash from Operations figures stand at 228763000.0 (Q1 2026), 6067000.0 (Q4 2025), and 39681000.0 (Q3 2025).